148 related articles for article (PubMed ID: 21891979)
1. [Cryptococcosis].
Kakeya H; Kohno S
Med Mycol J; 2011; 52(3):183-91. PubMed ID: 21891979
[No Abstract] [Full Text] [Related]
2. A murine model of Cryptococcus gattii meningoencephalitis.
Thompson GR; Wiederhold NP; Najvar LK; Bocanegra R; Kirkpatrick WR; Graybill JR; Patterson TF
J Antimicrob Chemother; 2012 Jun; 67(6):1432-8. PubMed ID: 22378683
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary cryptococcosis.
Brizendine KD; Baddley JW; Pappas PG
Semin Respir Crit Care Med; 2011 Dec; 32(6):727-34. PubMed ID: 22167400
[TBL] [Abstract][Full Text] [Related]
4. Models for Inducing Experimental Cryptococcosis in Mice.
Castro-Lopez N; Wormley FL
Methods Mol Biol; 2024; 2775():29-46. PubMed ID: 38758309
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
6. Ten challenges on Cryptococcus and cryptococcosis.
Del Poeta M; Casadevall A
Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation.
Nematollahi S; Dioverti-Prono V
Mycoses; 2020 Oct; 63(10):1033-1046. PubMed ID: 32740974
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcosis.
Negroni R
Clin Dermatol; 2012; 30(6):599-609. PubMed ID: 23068147
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
Kwon-Chung KJ; Fraser JA; Doering TL; Wang Z; Janbon G; Idnurm A; Bahn YS
Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a019760. PubMed ID: 24985132
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcus and cryptococcosis in Cuba. A minireview.
Illnait-Zaragozi MT; Martínez-Machín GF; Fernández-Andreu CM; Perurena-Lancha MR; Hagen F; Meis JF
Mycoses; 2014 Dec; 57(12):707-17. PubMed ID: 25420448
[TBL] [Abstract][Full Text] [Related]
11. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y
Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391
[TBL] [Abstract][Full Text] [Related]
12. Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy.
Maestrale C; Masia M; Pintus D; Lollai S; Kozel TR; Gates-Hollingsworth MA; Cancedda MG; Cabras P; Pirino S; D'Ascenzo V; Ligios C
Vet Microbiol; 2015 Jun; 177(3-4):409-13. PubMed ID: 25840469
[TBL] [Abstract][Full Text] [Related]
13. [A case of successful treatment of brain and lung cryptococcosis caused by Cryptococcus gattii].
Horiuchi K; Yamada M; Shirai S; Takahashi I; Kano T; Kaneko Y; Akizawa K; Umeyama T; Miyazaki Y; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2012; 52(3):166-71. PubMed ID: 22453041
[TBL] [Abstract][Full Text] [Related]
14. Etiological factors of cryptococcosis - what makes them pathogens ?
Dylag M
Med Dosw Mikrobiol; 2015; 67(3-4):221-31. PubMed ID: 27019916
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E;
Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal therapies and drug targets: the old, the new and the promising.
Coelho C; Casadevall A
Cell Microbiol; 2016 Jun; 18(6):792-9. PubMed ID: 26990050
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China.
Li M; Liao Y; Chen M; Pan W; Weng L
Braz J Infect Dis; 2012; 16(2):175-9. PubMed ID: 22552461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
